These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27726215)

  • 1. Factors associated with current and severe physical side-effects after prostate cancer treatment: What men report.
    Steentjes L; Siesling S; Drummond FJ; van Manen JG; Sharp L; Gavin A
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 27726215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported 'ever had' and 'current' long-term physical symptoms after prostate cancer treatments.
    Gavin AT; Drummond FJ; Donnelly C; O'Leary E; Sharp L; Kinnear HR
    BJU Int; 2015 Sep; 116(3):397-406. PubMed ID: 25597493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.
    Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L
    BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain, fatigue and depression symptom cluster in survivors of prostate cancer.
    Baden M; Lu L; Drummond FJ; Gavin A; Sharp L
    Support Care Cancer; 2020 Oct; 28(10):4813-4824. PubMed ID: 31980895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.
    Kyrdalen AE; Dahl AA; Hernes E; Småstuen MC; Fosså SD
    BJU Int; 2013 Feb; 111(2):221-32. PubMed ID: 22672151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy versus deferred treatment for localised prostate cancer.
    Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
    Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
    JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
    Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
    BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.
    Kasperzyk JL; Shappley WV; Kenfield SA; Mucci LA; Kurth T; Ma J; Stampfer MJ; Sanda MG
    J Urol; 2011 Nov; 186(5):1862-7. PubMed ID: 21944095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy.
    Talcott JA; Rieker P; Propert KJ; Clark JA; Wishnow KI; Loughlin KR; Richie JP; Kantoff PW
    J Natl Cancer Inst; 1997 Aug; 89(15):1117-23. PubMed ID: 9262249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
    Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
    Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
    Lehto US; Tenhola H; Taari K; Aromaa A
    Br J Cancer; 2017 Mar; 116(7):864-873. PubMed ID: 28222069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of prostatectomy and brachytherapy in patients with localized prostate cancer.
    Reis F; Netto NR; Reinato JA; Thiel M; Zani E
    Int Urol Nephrol; 2004; 36(2):187-90. PubMed ID: 15368690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based study of long-term functional outcomes after prostate cancer treatment.
    Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
    BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
    Lilleby W; Fosså SD; Waehre HR; Olsen DR
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.